Skip to main content
. 2015 Dec;13(3-4):117–138. doi: 10.3121/cmr.2015.1272

Table 1.

Tuberculosis treatment outcomes (37 datasets from 18 studies)

Regimen Success Failed Relapsed Defaulted Total
Rifampicin throughout
 Intermittent* (n=9 datasets) 0.88 (0.81–0.92) 0.05 (0.02–0.09) 0.07 (0.03–0.11) 0.00 (0.00–0.02) 1
 Daily* (n=19 datasets) 0.90 (0.84–0.95) 0.04 (0.01–0.08) 0.01 (0.00–0.03) 0.05 (0.01–0.09) 1
 Overall 0.91 (0.84–0.95) 0.03 (0.01–0.08) 0.01 (0.00–0.03) 0.04 (0.01–0.09) 1
Rifampicin only in IP
 Daily* (n=9 datasets) 0.75 (0.57–0.91) 0.05(0.00–0.15) 0.02 (0.00–0.09) 0.15 (0.02–0.30) 1
*

These subjects had either the intermittent or daily therapy throughout (both phases)